Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

271 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Etanercept treatment for children and adolescents with plaque psoriasis.
Paller AS, Siegfried EC, Langley RG, Gottlieb AB, Pariser D, Landells I, Hebert AA, Eichenfield LF, Patel V, Creamer K, Jahreis A; Etanercept Pediatric Psoriasis Study Group. Paller AS, et al. Among authors: pariser d. N Engl J Med. 2008 Jan 17;358(3):241-51. doi: 10.1056/NEJMoa066886. N Engl J Med. 2008. PMID: 18199863 Free article. Clinical Trial.
AAD consensus statement on psoriasis therapies.
Callen JP, Krueger GG, Lebwohl M, McBurney EI, Mease P, Menter A, Paller AS, Pariser DM, Weinblatt M, Zimmerman G; AAD. Callen JP, et al. J Am Acad Dermatol. 2003 Nov;49(5):897-9. doi: 10.1016/s0190-9622(03)01870-x. J Am Acad Dermatol. 2003. PMID: 14576671 Review. No abstract available.
A novel targeted T-cell modulator, efalizumab, for plaque psoriasis.
Lebwohl M, Tyring SK, Hamilton TK, Toth D, Glazer S, Tawfik NH, Walicke P, Dummer W, Wang X, Garovoy MR, Pariser D; Efalizumab Study Group. Lebwohl M, et al. Among authors: pariser d. N Engl J Med. 2003 Nov 20;349(21):2004-13. doi: 10.1056/NEJMoa030002. N Engl J Med. 2003. PMID: 14627785 Free article. Clinical Trial.
Pimecrolimus cream 1%: a potential new treatment for chronic hand dermatitis.
Belsito DV, Fowler JF Jr, Marks JG Jr, Pariser DM, Hanifin J, Duarte IA, Pires MC, Cruz PD Jr, Langley RG, Patel P, Bush C, Thurston M, Graeber M, Cherill R; Multicenter Investigator Group. Belsito DV, et al. Among authors: pariser dm. Cutis. 2004 Jan;73(1):31-8. Cutis. 2004. PMID: 14964629 Clinical Trial.
Effect of a single course of isotretinoin therapy on bone mineral density in adolescent patients with severe, recalcitrant, nodular acne.
DiGiovanna JJ, Langman CB, Tschen EH, Jones T, Menter A, Lowe NJ, Eichenfield L, Hebert AA, Pariser D, Savin RP, Smith SR, Jarratt M, Rodriguez D, Chalker DK, Kempers S, Ling M, Rafal ES, Sullivan S, Kang S, Shah LP, Wu E, Newhouse J, Pak J, Eberhardt DR, Bryce GF, McLane JA, Ondovik M, Chin C, Khoo KC, Rich P. DiGiovanna JJ, et al. Among authors: pariser d. J Am Acad Dermatol. 2004 Nov;51(5):709-17. doi: 10.1016/j.jaad.2004.04.032. J Am Acad Dermatol. 2004. PMID: 15523348 Clinical Trial.
Low systemic absorption and good tolerability of pimecrolimus, administered as 1% cream (Elidel) in infants with atopic dermatitis--a multicenter, 3-week, open-label study.
Staab D, Pariser D, Gottlieb AB, Kaufmann R, Eichenfield LF, Langley RG, Scott G, Ebelin ME, Barilla D, Schmidli H, Burtin P. Staab D, et al. Among authors: pariser d. Pediatr Dermatol. 2005 Sep-Oct;22(5):465-71. doi: 10.1111/j.1525-1470.2005.00128.x. Pediatr Dermatol. 2005. PMID: 16191004 Clinical Trial.
271 results